<DOC>
	<DOCNO>NCT02119221</DOCNO>
	<brief_summary>The study aim provide understand relative relevance different excretion pathway Copanlisib human , well characterize metabolite profile .</brief_summary>
	<brief_title>Copanlisib Mass Balance Study</brief_title>
	<detailed_description />
	<criteria>Healthy male subject Age : 45 65 year Body weight great equal 60 kg body mass index ( BMI ) : above/equal 18 below/equal 30 kg/mÂ² Regular use medicine Known recent ( last 2 year ) abuse recreational drug , suspicion drug alcohol abuse , positive result drug alcohol screen test screen baseline Use strong inhibitor cytochrome P450 ( CYP ) 3A4 , well use St John 's Wort strong inducer CYP3A4 prohibit 14 day administration study drug discharge clinic Smoking Average intake 24 unit alcohol per week ; Regular daily consumption 1 L methylxanthinecontaining beverage Any condition , may result long usual retention urine feces body , pronounce ( less one defecation 2 day ) constipation symptomatic prostatic hypertrophy . Participation another mass balance study radiation burden &gt; 0.1 mSv period 1 year screening</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>